Profile of Relugolix in the Management of Advanced Hormone-Sensitive Prostate Cancer: Design, Development, and Place in Therapy
Tomoyuki Tatenuma,1,2 Hiroshi Miyamoto1,3 1Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA; 2Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan; 3Department of Urology, University of Rochester Med...
Saved in:
Main Authors: | Tatenuma T (Author), Miyamoto H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Docetaxel in hormone-sensitive advanced prostate cancer; GENESIS-SEFH evaluation reporta
by: Emilio Jesús Alegre del Rey, et al.
Published: (2017) -
Profile of Fruquintinib in the Management of Advanced Refractory Metastatic Colorectal Cancer: Design, Development and Potential Place in Therapy
by: Syaj S, et al.
Published: (2024) -
Assessment of androgen receptor signaling inhibitors therapy in metastatic hormone-sensitive prostate cancer
by: Jukapun Yoodee, et al.
Published: (2022) -
Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy
by: Romigi A, et al.
Published: (2018) -
A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy
by: Yukifumi Sasamori, et al.
Published: (2021)